Scientia Advisors - Science, knowledge and skill for your competitive advantage

Biopharmaceutical Market

LinkedIn Facebook Twitter Delicious

Industry Reviews

Assessing the Biopharmaceutical Market: Promises and Challenges

With the market for biologic drugs growing much faster than that of drugs based on chemical compounds, industry players are repositioning and forming new alliances in order to succeed in a rapidly changing pharmaceutical landscape. This review assesses three main drivers of change: (1) the emergence of biologics (therapeutics based on living matter rather than on chemical compounds; (2) new technologies for bioproduction (the manufacturing of biologics, which typically relies on living cells); and (3) the expiration of patents for numerous biologics, which will likely create opportunities for "biosimilars", (government approved new versions of branded biopharmaceutical products following patent expiration). The review also analyzes how these trends combined are leading to new opportunities and challenges for the biomedical industries.

SCIENTIA ADVISORS, LLC  |  |  A Precision for Medicine Company

55 Cambridge Parkway, Suite 300E, Cambridge MA 02142  |  Phone: 617-299-3000  |  Fax: 617-812-0315

© 2014 Scientia Advisors LLC